Stage migration as a surrogate of survival in hepatocellular carcinoma treated with transarterial chemoembolization.
Ihab KassabAmit G SingalAamir AliManasa NarasimmanAshwini ArvindMuneeb AhmedSagar JoshiKomal ManzoorNicole E RichVincent L ChenZhe ZhaoAmmar SarwarNeehar D ParikhPublished in: Hepatology communications (2023)
Stage migration is associated with increased mortality after TACE in patients with HCC and could serve as a surrogate end point in clinical trials evaluating locoregional therapies such as TACE.